Logotype for Oceania Healthcare Limited

Oceania Healthcare (OCA) H1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Oceania Healthcare Limited

H1 2026 earnings summary

8 Jul, 2026

Executive summary

  • Achieved a significant turnaround with improved sales, cost efficiencies, and disciplined capital management, including a 5% increase in sales volumes and strong presales at key developments.

  • Realized $4 million in cost savings in 1HY26, with $13.2 million on track for FY26 and annualized cost savings of $20.4 million identified.

  • Gearing reduced to 34.8%, within the 30–35% target range, and divestments of four sites are progressing for completion in FY26.

  • Operating cash flow strengthened, positioning the business for further improvement in the second half.

  • Integrated care model and strategic focus on sales, business excellence, and capital management drive improved results.

Financial highlights

  • Total comprehensive income rose to $40.4 million, up $28.6 million year-over-year, driven by property revaluations and improved operational performance.

  • Proforma underlying EBITDA increased 23.2% to $41.9 million, and proforma underlying NPAT rose 18.9% to $24.1 million.

  • Operating cash flow grew 12.2% to $79.0 million, and net tangible assets per share increased 3.8% to $1.57.

  • Net debt decreased to $608.9 million, with $116 million headroom on facilities and total assets surpassing $3.0 billion.

  • No interim dividend declared, with focus on free cash flow sustainability before resuming payments.

Outlook and guidance

  • FY26 remains a stabilization year, with focus on lifting sales cadence, reducing unsold and aged stock, and delivering $13.2 million in targeted savings.

  • Targeting full recovery of development costs at The Helier by March 2026 and completion of Stage One at Franklin, with four divestments targeting $40 million in capital release.

  • Management expects at least similar or higher sales volumes in the second half, with strong application momentum supporting settlements.

  • Plans to implement $20.4 million in annualized cost-out initiatives from FY27 and return to positive free cash flow before resuming dividends.

  • Development activity will be paced to market conditions, targeting 100–150 units per year.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more